For people with vitiligo and their caregivers
What this page helps you do
Understand paths outside routine topical or light treatment without treating surgery, depigmentation, camouflage, or no active treatment as a ranked ladder.
- Your task
- Compare realistic paths without treating the page as a personalized recommendation.
- The clinician boundary
- Diagnosis, assessment of activity and body sites, prescribing, monitoring, and personalized treatment decisions belong to a qualified clinician.
Compare these realistic paths consistently
These paths are not ranked. Use the same factors for each option that remains realistic after clinical review.
When might a surgical or cell-based procedure be discussed?
Procedures may be discussed for carefully selected people whose vitiligo is judged clinically stable, often after other paths have not met the goal. Stability, body site, healing, access, specialist experience, and expectations all matter.
Guidelines and systematic reviews describe grafting and cell-transfer approaches for selected stable vitiligo. In the United States, one cell-harvesting system has a defined vitiligo authorization for selected adults in trained settings.
“Stable” is a clinical judgment, not a self-test. Evidence is often nonrandomized, and eligibility for one procedure does not establish eligibility for another.
Compare the time, follow-up, daily effort, and practical burden of this exact path.
Confirm current availability, qualified support, coverage, and personal cost before relying on this path.
Ask what can be stopped or revisited and which outcomes remain uncertain.
What outcomes and harms should I understand before a procedure?
Ask about incomplete or uneven color return, mismatched color or texture, scarring, healing, and how long results may last. Also ask what support is available if the result misses your goal. A procedure cannot guarantee a lasting or even-looking result.
Published techniques and outcomes vary, as do study quality and adverse-effect reporting. Body site and operator experience can affect what is realistic.
Average study results cannot predict your color match, satisfaction, healing, or relapse. Costs and coverage may be uncertain.
Compare the time, follow-up, daily effort, and practical burden of this exact path.
Confirm current availability, qualified support, coverage, and personal cost before relying on this path.
Ask what can be stopped or revisited and which outcomes remain uncertain.
What is depigmentation therapy?
Depigmentation is a specialist path that reduces remaining color for selected people with extensive vitiligo. It is not a routine cosmetic shortcut. The change may be permanent and may create lifelong sun-sensitivity concerns. It requires careful medical and mental-health discussion.
International guidance includes depigmentation among selected management strategies rather than placing it on a universal treatment ladder. The goal is different from repigmentation.
Suitability, access, product status, outcome, and reversibility vary by person and jurisdiction. Any named product needs its own evidence, status, and clinical instructions.
Compare the time, follow-up, daily effort, and practical burden of this exact path.
Confirm current availability, qualified support, coverage, and personal cost before relying on this path.
Ask what can be stopped or revisited and which outcomes remain uncertain.
Are camouflage or no active treatment legitimate choices?
Yes. You may use camouflage, cosmetics, self-tanning products, clothing, or no concealment; you may also choose no active medical treatment. These choices can change over time and do not mean you have given up.
Patient and clinical guidance recognize appearance support, psychosocial support, and choosing not to pursue repigmentation. You can still seek diagnosis, skin protection guidance, emotional support, and a plan for future changes.
Individual products differ in ingredients, finish, sensitivity, and cost. Choosing no active treatment does not predict that vitiligo will remain unchanged.
Compare the time, follow-up, daily effort, and practical burden of this exact path.
Confirm current availability, qualified support, coverage, and personal cost before relying on this path.
Ask what can be stopped or revisited and which outcomes remain uncertain.
When might a surgical or cell-based procedure be discussed?
Procedures may be discussed for carefully selected people whose vitiligo is judged clinically stable, often after other paths have not met the goal. Stability, body site, healing, access, specialist experience, and expectations all matter. Evidence Evidence
Why this matters
Guidelines and systematic reviews describe grafting and cell-transfer approaches for selected stable vitiligo. In the United States, one cell-harvesting system has a defined vitiligo authorization for selected adults in trained settings.
What outcomes and harms should I understand before a procedure?
Ask about incomplete or uneven color return, mismatched color or texture, scarring, healing, and how long results may last. Also ask what support is available if the result misses your goal. A procedure cannot guarantee a lasting or even-looking result. Evidence Evidence
Why this matters
Published techniques and outcomes vary, as do study quality and adverse-effect reporting. Body site and operator experience can affect what is realistic.
What is depigmentation therapy?
Depigmentation is a specialist path that reduces remaining color for selected people with extensive vitiligo. It is not a routine cosmetic shortcut. The change may be permanent and may create lifelong sun-sensitivity concerns. It requires careful medical and mental-health discussion. Evidence Evidence
Why this matters
International guidance includes depigmentation among selected management strategies rather than placing it on a universal treatment ladder. The goal is different from repigmentation.
Are camouflage or no active treatment legitimate choices?
Yes. You may use camouflage, cosmetics, self-tanning products, clothing, or no concealment; you may also choose no active medical treatment. These choices can change over time and do not mean you have given up. Evidence Evidence
Why this matters
Patient and clinical guidance recognize appearance support, psychosocial support, and choosing not to pursue repigmentation. You can still seek diagnosis, skin protection guidance, emotional support, and a plan for future changes.
Questions that can change the next decision
- For your clinicianWhich permanent changes and skin-protection needs matter?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- For your clinicianIf I choose no active treatment, what changes should I keep track of?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- For your clinicianWhere can I find camouflage help without pressure to conceal?Saving keeps this on your device and needs JavaScript, which is off in this browser.
Applicability check
Who was studied?
These fields show what the cited evidence reports about the people and body sites behind outcome or safety claims. “Not reported” means the reviewed source omitted the field; “Pending exact source review” means SteadySkin has not made that determination yet.
Ask about incomplete or uneven color return, mismatched color or texture, scarring, healing, and how long results may last. Also ask what support is available if the result misses your goal. A procedure cannot guarantee a lasting or even-looking result.
- Age range
- Pending exact source review
- Condition subtype
- Pending exact source review
- Severity or extent
- Pending exact source review
- Sample size
- Pending exact source review
- Geography and care setting
- Pending exact source review
- Skin tone or phototype
- Pending exact source review
- Race
- Pending exact source review
- Ethnicity
- Pending exact source review
- Body sites
- Pending exact source review
What that means for this page: This is explicitly gated as a group-level outcome claim, but exact population extraction is still pending. It cannot publish or support an individual prediction until that review is complete.
Depigmentation is a specialist path that reduces remaining color for selected people with extensive vitiligo. It is not a routine cosmetic shortcut. The change may be permanent and may create lifelong sun-sensitivity concerns. It requires careful medical and mental-health discussion.
- Age range
- Pending exact source review
- Condition subtype
- Pending exact source review
- Severity or extent
- Pending exact source review
- Sample size
- Pending exact source review
- Geography and care setting
- Pending exact source review
- Skin tone or phototype
- Pending exact source review
- Race
- Pending exact source review
- Ethnicity
- Pending exact source review
- Body sites
- Pending exact source review
What that means for this page: This is explicitly gated as a safety claim, but exact population extraction is still pending. It cannot publish or support an estimate of individual risk until that review is complete.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Journal of the European Academy of Dermatology and VenereologyRegulatory / guideline · not independentRelevant relationship disclosed
- Published
- 2023-09-15
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
Why the independence label says this: The journal is the publisher. This label refers to extensive author relationships disclosed for the recommendation, not to the journal itself.
What this source supports
Supports an expert-consensus map of established, off-label and developing Vitiligo treatment categories and makes clear that research is continuing.
What it does not support
It is an international consensus with extensive author relationships, not independent comparative proof, current U.S. regulatory status for every option or a personal treatment sequence.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- U.S. Food and Drug AdministrationRegulatory / guideline · independentIndependent source
- Published
- 2023-06-16
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports FDA authorization of this device for repigmentation of stable depigmented vitiligo lesions in a defined adult population and trained professional setting.
What it does not support
It does not approve every grafting procedure, define stability for a reader or guarantee color match, durability or satisfaction.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- JAMA Dermatology (Ju HJ, et al.)Clinical research · not independentIndependence not established
- Published
- 2021-02-17
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports that multiple surgical techniques have been studied for selected stable vitiligo and that reported response and adverse effects vary by method and study.
What it does not support
Much of the evidence is nonrandomized and an author reported industry relationships; the review does not determine stability, eligibility, color match, durability or individual outcome.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- British Journal of Dermatology (Eleftheriadou V, et al.)Regulatory / guideline · independentIndependent source
- Published
- 2022-01-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports the clinical history and assessment domains, evaluation of associated autoimmune conditions, its recommendation for thyroid function and antithyroid antibody screening, current classification context, treatment-option map, psychosocial assessment, medical photography and the limits of pediatric evidence.
What it does not support
It was designed for UK care and reviewed literature through May 2019; it does not establish a universal testing plan, prescribe an individual plan, or establish current US labeling or coverage.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · independentIndependent source
- Published
- 2022-10-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports a patient-facing description of clinician diagnosis using history and examination, possible use of a Wood lamp and selected tests, broad treatment categories, variable response and whole-person support.
What it does not support
It is educational context, not primary efficacy evidence, an online diagnostic method or a universal testing checklist.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- American Academy of DermatologyPatient education · not independentIndependence not established
- Published
- 2026-04-15
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports current US patient-language context that lighter patches have multiple causes, dermatologists diagnose vitiligo from history and examination, treatment is optional and several broad management paths exist.
What it does not support
The page acknowledges support from Incyte Dermatology, so it does not independently establish drug efficacy or comparative superiority.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.